TreeWAS – Variant ID: rs493733

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H57.0 Anomalies of pupillary function	0.000	0.990	0.010
I85.9 Oesophageal varices without bleeding	0.000	0.991	0.009
C64 Malignant neoplasm of kidney, except renal pelvis	0.009	0.991	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.992	0.008
H57 Other disorders of eye and adnexa	0.000	0.992	0.008
D86.9 Sarcoidosis, unspecified	0.000	0.992	0.008
H57.1 Ocular pain	0.000	0.993	0.007
H02.0 Entropion and trichiasis of eyelid	0.000	0.993	0.007
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.993	0.007
Z35.1 Supervision of pregnancy with history of abortive outcome	0.006	0.994	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.994	0.006
I85 Oesophageal varices	0.000	0.995	0.005
M25.84 Other specified joint disorders (Hand)	0.005	0.995	0.000
I85.0 Oesophageal varices with bleeding	0.000	0.995	0.005
K70.9 Alcoholic liver disease, unspecified	0.000	0.995	0.005
D50.8 Other iron deficiency anaemias	0.004	0.996	0.000
M54.16 Radiculopathy (Lumbar region)	0.004	0.996	0.000
L05 Pilonidal cyst	0.000	0.996	0.004
R58 Haemorrhage, not elsewhere classified	0.004	0.996	0.000
K70 Alcoholic liver disease	0.000	0.996	0.004
K65.0 Acute peritonitis	0.004	0.996	0.000
R90.0 Intracranial space-occupying lesion	0.004	0.996	0.000
D86 Sarcoidosis	0.000	0.996	0.004
K70.3 Alcoholic cirrhosis of liver	0.000	0.996	0.004
K70.0 Alcoholic fatty liver	0.000	0.996	0.003
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.996	0.003
K70.1 Alcoholic hepatitis	0.000	0.997	0.003
M50.2 Other cervical disk displacement	0.000	0.997	0.003
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
H57.8 Other specified disorders of eye and adnexa	0.000	0.997	0.003
L05.0 Pilonidal cyst with abscess	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
G12.2 Motor neuron disease	0.003	0.997	0.000
M25.8 Other specified joint disorders	0.003	0.997	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.997	0.003
I12.9 Hypertensive renal disease without renal failure	0.000	0.997	0.003
M20.5 Other deformities of toe(s) (acquired)	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M25.88 Other specified joint disorders (Other)	0.003	0.997	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.997	0.003
S82.40 Fracture of fibula alone (closed)	0.003	0.997	0.000
G82.5 Tetraplegia, unspecified	0.003	0.997	0.000
G12 Spinal muscular atrophy and related syndromes	0.003	0.997	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.997	0.003
G10 Huntington's disease	0.003	0.997	0.000
N30.8 Other cystitis	0.003	0.997	0.000
S32.50 Fracture of pubis (closed)	0.003	0.997	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.997	0.003
G11 Hereditary ataxia	0.003	0.997	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.003	0.997	0.000
M25.82 Other specified joint disorders (Upper arm)	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
M60.08 Infective myositis (Other)	0.000	0.997	0.003
G11.4 Hereditary spastic paraplegia	0.003	0.997	0.000
D86.3 Sarcoidosis of skin	0.000	0.997	0.003
M25.83 Other specified joint disorders (Forearm)	0.003	0.997	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.997	0.003
M25.89 Other specified joint disorders (Site unspecified)	0.003	0.997	0.000
M25.80 Other specified joint disorders (Multiple sites)	0.003	0.997	0.000
I77.6 Arteritis, unspecified	0.000	0.997	0.003
T40.2 Other opioids	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
E29.1 Testicular hypofunction	0.003	0.997	0.000
I15.1 Hypertension secondary to other renal disorders	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
G91.0 Communicating hydrocephalus	0.002	0.997	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.002	0.998	0.000
G12.9 Spinal muscular atrophy, unspecified	0.002	0.998	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.002	0.998	0.000
G12.1 Other inherited spinal muscular atrophy	0.002	0.998	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
G14 Postpolio syndrome	0.002	0.998	0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.002	0.998	0.000
G11.1 Early-onset cerebellar ataxia	0.002	0.998	0.000
K70.4 Alcoholic hepatic failure	0.000	0.998	0.002
T51.0 Ethanol	0.002	0.998	0.000
Z58.1 Exposure to air pollution	0.000	0.998	0.002
D10.1 Tongue	0.000	0.998	0.002
N36.2 Urethral caruncle	0.000	0.998	0.002
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
H81.0 Meniere's disease	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.000	0.998	0.002
S90.9 Superficial injury of ankle and foot, unspecified	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.002	0.998	0.000
G11.9 Hereditary ataxia, unspecified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
Z04.9 Examination and observation for unspecified reason	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
G11.8 Other hereditary ataxias	0.002	0.998	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.002	0.998	0.000
G11.2 Late-onset cerebellar ataxia	0.002	0.998	0.000
G11.0 Congenital nonprogressive ataxia	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
M25.87 Other specified joint disorders (Ankle and foot)	0.002	0.998	0.000
M50.0 Cervical disk disorder with myelopathy	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)	0.002	0.998	0.000
G82.1 Spastic paraplegia	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
H02.5 Other disorders affecting eyelid function	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.998	0.002
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)	0.002	0.998	0.000
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.002	0.998	0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.002	0.998	0.000
J03.9 Acute tonsillitis, unspecified	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.998	0.002
M17.3 Other posttraumatic gonarthrosis	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.002	0.998	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.002	0.998	0.000
G82.0 Flaccid paraplegia	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
I15.9 Seconday hypertension, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
G82.3 Flaccid tetraplegia	0.002	0.998	0.000
L29.0 Pruritus ani	0.000	0.998	0.002
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.000	0.998	0.002
S50.0 Contusion of elbow	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
M25.86 Other specified joint disorders (Lower leg)	0.002	0.998	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
G82.4 Spastic tetraplegia	0.002	0.998	0.000
M60.0 Infective myositis	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
B37.8 Candidiasis of other sites	0.002	0.998	0.000
I15 Secondary hypertension	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
M50.8 Other cervical disk disorders	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
M50 Cervical disk disorders	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
S82.4 Fracture of fibula alone	0.002	0.998	0.000
M60.05 Infective myositis (Pelvic region and thigh)	0.000	0.998	0.002
J37.0 Chronic laryngitis	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.998	0.002
S90.0 Contusion of ankle	0.000	0.998	0.002
S32.5 Fracture of pubis	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
S22.50 Flail chest (closed)	0.002	0.998	0.000
I15.0 Renovascular hypertension	0.000	0.998	0.002
O42.9 Premature rupture of membranes, unspecified	0.000	0.998	0.002
N04.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.002	0.998	0.000
B44.9 Aspergillosis, unspecified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
S90.8 Other superficial injuries of ankle and foot	0.000	0.998	0.002
G91.9 Hydrocephalus, unspecified	0.002	0.998	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.998	0.002
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
T36.4 Tetracyclines	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
S90 Superficial injury of ankle and foot	0.000	0.998	0.002
M60.09 Infective myositis (Site unspecified)	0.000	0.998	0.001
M60.07 Infective myositis (Ankle and foot)	0.000	0.998	0.001
M60.06 Infective myositis (Lower leg)	0.000	0.998	0.001
M60.04 Infective myositis (Hand)	0.000	0.998	0.001
M60.03 Infective myositis (Forearm)	0.000	0.998	0.001
M60.02 Infective myositis (Upper arm)	0.000	0.998	0.001
M60.01 Infective myositis (Shoulder region)	0.000	0.998	0.001
M60.00 Infective myositis (Multiple sites)	0.000	0.998	0.001
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.000	0.998	0.002
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.000	0.998	0.002
I15.8 Other secondary hypertension	0.000	0.998	0.001
I15.2 Hypertension secondary to endocrine disorders	0.000	0.998	0.001
T41.5 Therapeutic gases	0.001	0.998	0.000
T41.4 Anaesthetic, unspecified	0.001	0.998	0.000
T41.3 Local anaesthetics	0.001	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
T41.1 Intravenous anaesthetics	0.001	0.998	0.000
T41.0 Inhaled anaesthetics	0.001	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.001	0.998	0.000
Z96.0 Presence of urogenital implants	0.000	0.998	0.002
M24.85 Other specific joint derangements, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.998	0.002
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.002	0.998	0.000
O66.0 Obstructed labour due to shoulder dystocia	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.998	0.000
Z32.1 Pregnancy confirmed	0.000	0.998	0.002
M49.5 Collapsed vertebra in diseases classified elsewhere	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S82.41 Fracture of fibula alone (open)	0.001	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
Q85.1 Tuberous sclerosis	0.001	0.998	0.000
S90.1 Contusion of toe(s) without damage to nail	0.000	0.998	0.001
T40.4 Other synthetic narcotics	0.002	0.998	0.000
M49.50 Collapsed vertebra in diseases classified elsewhere (Multiple sites in spine)	0.001	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
X78.0 Home	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.998	0.002
M79.16 Myalgia (Lower leg)	0.002	0.998	0.000
S32.51 Fracture of pubis (open)	0.001	0.998	0.000
G91.2 Normal-pressure hydrocephalus	0.001	0.998	0.000
N04.0 Minor glomerular abnormality	0.000	0.998	0.001
T43.6 Psychostimulants with abuse potential	0.001	0.998	0.000
T45.5 Anticoagulants	0.001	0.998	0.000
Z58.8 Other problems related to physical environment	0.000	0.998	0.001
B16 Acute hepatitis B	0.000	0.998	0.001
N48.2 Other inflammatory disorders of penis	0.002	0.998	0.000
A41.9 Septicaemia, unspecified	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.998	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.998	0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.998	0.001
L60.9 Nail disorder, unspecified	0.000	0.998	0.001
M50.9 Cervical disk disorder, unspecified	0.000	0.998	0.001
Q85.8 Other phakomatoses, not elsewhere classified	0.001	0.998	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.999	0.001
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.999	0.001
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.999	0.001
S90.7 Multiple superficial injuries of ankle and foot	0.000	0.999	0.001
S90.2 Contusion of toe(s) with damage to nail	0.000	0.999	0.001
S82.00 Fracture of patella (closed)	0.001	0.999	0.000
D10.0 Lip	0.000	0.999	0.001
O43.8 Other placental disorders	0.000	0.999	0.001
X78.2 School, other institution and public administrative area	0.001	0.999	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.999	0.001
Z58 Problems related to physical environment	0.000	0.999	0.001
D68.0 Von Willebrand's disease	0.000	0.999	0.001
N04.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
N04 Nephrotic syndrome	0.000	0.999	0.001
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.001	0.999	0.000
G91 Hydrocephalus	0.001	0.999	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
M49.59 Collapsed vertebra in diseases classified elsewhere (Site unspecified)	0.001	0.999	0.000
M49.58 Collapsed vertebra in diseases classified elsewhere (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M49.57 Collapsed vertebra in diseases classified elsewhere (Lumbosacral region)	0.001	0.999	0.000
M49.55 Collapsed vertebra in diseases classified elsewhere (Thoracolumbar region)	0.001	0.999	0.000
M49.53 Collapsed vertebra in diseases classified elsewhere (Cervicothoracic region)	0.001	0.999	0.000
M49.52 Collapsed vertebra in diseases classified elsewhere (Cervical region)	0.001	0.999	0.000
M49.51 Collapsed vertebra in diseases classified elsewhere (Occipito-atlanto-axial region)	0.001	0.999	0.000
Q07.0 Arnold-Chiari syndrome	0.001	0.999	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.001	0.999	0.000
T45.8 Other primarily systemic and haematological agents	0.001	0.999	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.999	0.000
T45.6 Fibrinolysis-affecting drugs	0.001	0.999	0.000
T45.4 Iron and its compounds	0.001	0.999	0.000
T45.3 Enzymes, not elsewhere classified	0.001	0.999	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.001	0.999	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.999	0.001
C84.4 Peripheral T-cell lymphoma	0.001	0.999	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.999	0.001
N04.9 Unspecified	0.000	0.999	0.001
T40.6 Other and unspecified narcotics	0.001	0.999	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.000	0.999	0.001
Z73.3 Stress, not elsewhere classified	0.000	0.999	0.001
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.999	0.001
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.000	0.999	0.001
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.000	0.999	0.001
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.000	0.999	0.001
C80.9 Malignant neoplasm, unspecified	0.000	0.999	0.001
D89.1 Cryoglobulinaemia	0.000	0.999	0.001
H60.1 Cellulitis of external ear	0.001	0.999	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
N05.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
M49.56 Collapsed vertebra in diseases classified elsewhere (Lumbar region)	0.001	0.999	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.001	0.999	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.999	0.001
M79.54 Residual foreign body in soft tissue (Hand)	0.001	0.999	0.000
D16.4 Bones of skull and face	0.001	0.999	0.000
G50.0 Trigeminal neuralgia	0.001	0.999	0.000
T43.9 Psychotropic drug, unspecified	0.001	0.999	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.999	0.000
W84.9 Unspecified place	0.001	0.999	0.000
Z35.5 Supervision of elderly primigravida	0.000	0.999	0.001
F79 Unspecified mental retardation	0.001	0.999	0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.001	0.999	0.000
D89.3 Immune reconstitution syndrome	0.000	0.999	0.001
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.999	0.001
Q66.8 Other congenital deformities of feet	0.000	0.999	0.001
W10.8 Other specified place	0.000	0.999	0.001
Z58.9 Problem related to physical environment, unspecified	0.000	0.999	0.001
Z58.6 Inadequate drinking-water supply	0.000	0.999	0.001
Z58.4 Exposure to radiation	0.000	0.999	0.001
Z58.3 Exposure to soil pollution	0.000	0.999	0.001
Z58.2 Exposure to water pollution	0.000	0.999	0.001
Z58.0 Exposure to noise	0.000	0.999	0.001
B18 Chronic viral hepatitis	0.000	0.999	0.001
G91.3 Posttraumatic hydrocephalus, unspecified	0.001	0.999	0.000
M50.1 Cervical disk disorder with radiculopathy	0.000	0.999	0.001
N04.8 Other	0.000	0.999	0.001
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.999	0.001
N04.6 Dense deposit disease	0.000	0.999	0.001
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.999	0.001
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.999	0.001
T38.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
T38.7 Androgens and anabolic congeners	0.001	0.999	0.000
T38.5 Other oestrogens and progestogens	0.001	0.999	0.000
T38.4 Oral contraceptives	0.001	0.999	0.000
T38.2 Antithyroid drugs	0.001	0.999	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.999	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
M24.88 Other specific joint derangements, not elsewhere classified (Other)	0.001	0.999	0.000
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.001	0.999	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.001	0.999	0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.000	0.999	0.001
C18.2 Ascending colon	0.001	0.999	0.000
H61.1 Non-infective disorders of pinna	0.001	0.999	0.000
Z58.7 Exposure to tobacco smoke	0.000	0.999	0.001
Z58.5 Exposure to other pollution	0.000	0.999	0.001
C49.3 Connective and soft tissue of thorax	0.000	0.999	0.001
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.999	0.001
M24.8 Other specific joint derangements, not elsewhere classified	0.001	0.999	0.000
Q10.0 Congenital ptosis	0.001	0.999	0.000
T36.0 Penicillins	0.001	0.999	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.999	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.001	0.999	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.999	0.000
X78 Intentional self-harm by sharp object	0.001	0.999	0.000
C26.0 Intestinal tract, part unspecified	0.001	0.999	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.999	0.001
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.999	0.001
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.001	0.999	0.000
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)	0.001	0.999	0.000
M79.56 Residual foreign body in soft tissue (Lower leg)	0.001	0.999	0.000
F79.8 Unspecified mental retardation (Other impairments of behaviour)	0.001	0.999	0.000
F79.1 Unspecified mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.001	0.999	0.000
F79.0 Unspecified mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.001	0.999	0.000
S90.3 Contusion of other and unspecified parts of foot	0.000	0.999	0.001
D81 Combined immunodeficiencies	0.000	0.999	0.001
B18.9 Chronic viral hepatitis, unspecified	0.000	0.999	0.001
I88.9 Nonspecific lymphadenitis, unspecified	0.000	0.999	0.001
M51.9 Intervertebral disk disorder, unspecified	0.001	0.999	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.999	0.001
S91.3 Open wound of other parts of foot	0.001	0.999	0.000
T42.3 Barbiturates	0.001	0.999	0.000
T51 Toxic effect of alcohol	0.001	0.999	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.001	0.999	0.000
B18.8 Other chronic viral hepatitis	0.000	0.999	0.001
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.999	0.001
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.999	0.001
H01.9 Inflammation of eyelid, unspecified	0.001	0.999	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Y04.2 School, other institution and public administrative area	0.001	0.999	0.000
O66 Other obstructed labour	0.001	0.999	0.000
M24.89 Other specific joint derangements, not elsewhere classified (Site unspecified)	0.001	0.999	0.000
M24.80 Other specific joint derangements, not elsewhere classified (Multiple sites)	0.001	0.999	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
M79.53 Residual foreign body in soft tissue (Forearm)	0.001	0.999	0.000
B37.4 Candidiasis of other urogenital sites	0.001	0.999	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.999	0.001
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.999	0.001
G60.0 Hereditary motor and sensory neuropathy	0.000	0.999	0.001
O66.9 Obstructed labour, unspecified	0.001	0.999	0.000
O66.8 Other specified obstructed labour	0.001	0.999	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
S61.0 Open wound of finger(s) without damage to nail	0.001	0.999	0.000
S64.3 Injury of digital nerve of thumb	0.001	0.999	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.999	0.001
E29 Testicular dysfunction	0.001	0.999	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.999	0.001
F45.3 Somatoform autonomic dysfunction	0.001	0.999	0.000
H60.4 Cholesteatoma of external ear	0.001	0.999	0.000
K09.2 Other cysts of jaw	0.001	0.999	0.000
X78.9 Unspecified place	0.001	0.999	0.000
X78.8 Other specified place	0.001	0.999	0.000
X78.7 Farm	0.001	0.999	0.000
X78.6 Industrial and construction area	0.001	0.999	0.000
X78.5 Trade and service area	0.001	0.999	0.000
X78.4 Street and highway	0.001	0.999	0.000
X78.3 Sports and athletics area	0.001	0.999	0.000
X78.1 Residential institution	0.001	0.999	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.999	0.001
N05 Unspecified nephritic syndrome	0.000	0.999	0.001
M24.84 Other specific joint derangements, not elsewhere classified (Hand)	0.001	0.999	0.000
M65.83 Other synovitis and tenosynovitis (Forearm)	0.000	0.999	0.001
M79.19 Myalgia (Site unspecified)	0.001	0.999	0.000
M79.15 Myalgia (Pelvic region and thigh)	0.001	0.999	0.000
S42.30 Fracture of shaft of humerus (closed)	0.001	0.999	0.000
C49.5 Connective and soft tissue of pelvis	0.000	0.999	0.001
D81.9 Combined immunodeficiency, unspecified	0.000	0.999	0.001
D81.8 Other combined immunodeficiencies	0.000	0.999	0.001
D81.7 Major histocompatibility complex class II deficiency	0.000	0.999	0.001
D81.6 Major histocompatibility complex class I deficiency	0.000	0.999	0.001
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.999	0.001
D81.4 Nezelof's syndrome	0.000	0.999	0.001
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.999	0.001
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.999	0.001
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.999	0.001
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.999	0.001
I06.0 Rheumatic aortic stenosis	0.000	0.999	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.001	0.999	0.000
T42.2 Succinimides and oxazolidinediones	0.001	0.999	0.000
O42 Premature rupture of membranes	0.000	0.999	0.001
G61.8 Other inflammatory polyneuropathies	0.000	0.999	0.001
G80.9 Infantile cerebral palsy, unspecified	0.001	0.999	0.000
M79.5 Residual foreign body in soft tissue	0.001	0.999	0.000
O66.3 Obstructed labour due to other abnormalities of foetus	0.001	0.999	0.000
O66.1 Obstructed labour due to locked twins	0.001	0.999	0.000
T51.8 Other alcohols	0.001	0.999	0.000
T51.3 Fusel oil	0.001	0.999	0.000
T51.2 2-Propanol	0.001	0.999	0.000
T51.1 Methanol	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.999	0.001
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.999	0.001
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.999	0.001
D82.2 Immunodeficiency with short-limbed stature	0.000	0.999	0.001
D82.0 Wiskott-Aldrich syndrome	0.000	0.999	0.001
E29.9 Testicular dysfunction, unspecified	0.001	0.999	0.000
E29.8 Other testicular dysfunction	0.001	0.999	0.000
E29.0 Testicular hyperfunction	0.001	0.999	0.000
G80.8 Other infantile cerebral palsy	0.001	0.999	0.000
G80.1 Spastic diplegia	0.001	0.999	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.001	0.999	0.000
H81.8 Other disorders of vestibular function	0.001	0.999	0.000
K75.9 Inflammatory liver disease, unspecified	0.001	0.999	0.000
N05.8 Other	0.000	0.999	0.001
N30.4 Irradiation cystitis	0.001	0.999	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.001	0.999	0.000
T38.1 Thyroid hormones and substitutes	0.001	0.999	0.000
G80 Infantile cerebral palsy	0.001	0.999	0.000
I12 Hypertensive renal disease	0.000	0.999	0.001
I83 Varicose veins of lower extremities	0.000	0.999	0.001
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.999	0.000
X78.99 Intentional self-harm by sharp object: Unspecified place: During unspecified activity	0.001	0.999	0.000
C68.0 Urethra	0.001	0.999	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.999	0.001
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations